Press
·
News
P+P advises Khanu Management on First Closing of its Technology Transfer Fund KHAN-I
Khanu Management GmbH is an investment management company with a focus on innovative drug discovery projects sourced from academic research in Germany and Austria. The management team has years of experience in the fields of drug research and development. KHAN Technology Transfer Fund I (KHAN-I), a German limited partnership, focusses on promoting technology transfer and translation in order to help transfer basic research in biotechnology to commercial drug development programs.
P+P partner Dr. Andreas Rodin advised the fund manager, Khanu Management GmbH, comprehensively on all contractual, tax and regulatory aspects of fund structuring and contractual documentation.